Establishment of a bank of third party T cells to treat virus infections (that are resistant or unsuitable for other forms of antibiotic therapy) in immunocompromised and transplant patients across Australia

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Bone marrow transplantation can cure cancers of the blood but patients are susceptible to viral infections due to ongoing immune deficiency. We have shown you can grow immune cells in the laboratory and transfer this immunity to transplant recipients. While effective, this has not been widely adopted due to the time, complexity and costs of the process. We aim to address these issues by providing a treatment option for patients with life threatening infections using immediately available “off the shelf” immune cells.

Funded Activity Details

Start Date: 01-01-2012

End Date: 01-01-2016

Funding Scheme: Project Grants

Funding Amount: $811,530.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Infectious Diseases

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

T cell immunotherapy | clinical trial | haematopoietic stem cell transplantation | immune deficiency | infectious diseases | novel therapies | translational research | transplant recipients | virology